People

The University of Cincinnati Medical Center has established a $6.5 million Center for Environmental Genetics and has named Daniel W. Nebert, a professor of environmental health, to be its first director. Nebert says the center is the first of its kind in the world to study the genetic link between environmental contaminants and human health. The center opened at the University of Cincinnati in mid-August in conjunction with the National Institutes of Health's National Institute of Environmental

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The University of Cincinnati Medical Center has established a $6.5 million Center for Environmental Genetics and has named Daniel W. Nebert, a professor of environmental health, to be its first director. Nebert says the center is the first of its kind in the world to study the genetic link between environmental contaminants and human health.

The center opened at the University of Cincinnati in mid-August in conjunction with the National Institutes of Health's National Institute of Environmental Health Sciences (NIEHS), based in Research Triangle Park, N.C. NIEHS provided the five-year grant to establish the center. It will begin with a staff of 25 investigators with research experience in genetics and biology from the University of Cincinnati. Nebert says the center's focus will be broad--isolating how and why every individual reacts differently to environmental factors. For example, explains Nebert, some people who smoke cigarettes will have a seven-out-of-100 chance of developing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies